A lymphocyte-specific protein tyrosine kinase (Lck), already found to be important in the evolution of chronic lymphocytic leukemia (CLL) [26], regulating Erk and Akt phosphorylation, is targeted by ABT-737 in our mouse model. This evidence concerns the gene LCK and B-cell chronic lymphocytic leukemia.